241. Hypertyrosinemia type I Clinical trials / Disease details

Clinical trials : 14 / Drugs : 7 - (DrugBank : 1) / Drug target gene : 1 - Drug target pathways : 5

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02750709 (ClinicalTrials.gov)	October 2015	20/4/2016	Bioequivalence Study of Two Nitisinone Formulations Compared to Orfadin	A Single Center, Single-Dose, Open-Label, Laboratory-Blind, Randomized, Three-Period Crossover Study ...	Hereditary Tyrosinemia, Type I	Drug: Nitisinone;Drug: Nitisinone 10 mg Tablet High Compritol;Drug: Orfadin	Cycle Pharmaceuticals Ltd.	Parexel	Completed	18 Years	55 Years	All	24	Phase 1	South Africa

First Previous1Next Last